Literature DB >> 24005909

Prostate cancer cell migration induced by myopodin isoforms is associated with formation of morphologically and biochemically distinct actin networks.

FuiBoon Kai1, Roy Duncan.   

Abstract

Myopodin is an actin-binding protein that promotes cancer cell migration in response to serum stimulation and is associated with invasive tumor development. To determine whether enhanced migration reflects changes in actin cytoskeleton remodeling, fluorescence confocal microscopy was used to examine the composition and morphology of filamentous actin structures in mock-transduced cells vs. stably transduced PC3 cells expressing human myopodin isoforms, and the chemokinetic response of cells was quantified using transwell assays. The same approaches were used to analyze the effects of external migration stimuli, actin polymerization inhibitors or deletion of the isoform-specific amino- and/or carboxy termini on cell migration and actin bundle formation. Results indicate that the termini of the myopodin isoforms differentially alter the formation of morphologically distinct F-actin networks that also differ in their myosin and myopodin staining patterns. Furthermore, enhanced cell migration was reduced by >50% when actin bundle formation was impaired by myopodin-truncation, low concentrations of an actin polymerization inhibitor, or in the absence of an external migration stimulus. Human myopodin isoforms are therefore potent regulators of stress fiber formation, inducing the formation of biochemically and morphologically distinct F-actin networks in the cell body whose presence directly correlates with increased cell migration.

Entities:  

Keywords:  PC3 cells; actin bundles; actomyosin; stress fibers; synaptopodin 2

Mesh:

Substances:

Year:  2013        PMID: 24005909     DOI: 10.1096/fj.13-231571

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  7 in total

1.  Prognostic Significance of Promoter Hypermethylation and Diminished Gene Expression of SYNPO2 in Melanoma.

Authors:  Linda Gao; Karin van den Hurk; Jérémie Nsengimana; Jonathan P Laye; Joost J van den Oord; Samuel Beck; Nelleke A Gruis; Willem H Zoutman; Manon van Engeland; Julia A Newton-Bishop; Véronique J Winnepenninckx; Remco van Doorn
Journal:  J Invest Dermatol       Date:  2015-04-28       Impact factor: 8.551

2.  Synaptopodin-2 induces assembly of peripheral actin bundles and immature focal adhesions to promote lamellipodia formation and prostate cancer cell migration.

Authors:  FuiBoon Kai; James P Fawcett; Roy Duncan
Journal:  Oncotarget       Date:  2015-05-10

3.  Dysregulated fibronectin trafficking by Hsp90 inhibition restricts prostate cancer cell invasion.

Authors:  Heather K Armstrong; Joanna L Gillis; Ian R D Johnson; Zeyad D Nassar; Max Moldovan; Claire Levrier; Martin C Sadowski; Mei Yieng Chin; Emma S Tomlinson Guns; Gerard Tarulli; David J Lynn; Douglas A Brooks; Luke A Selth; Margaret M Centenera; Lisa M Butler
Journal:  Sci Rep       Date:  2018-02-01       Impact factor: 4.379

Review 4.  The Complex Interplay between Chronic Inflammation, the Microbiome, and Cancer: Understanding Disease Progression and What We Can Do to Prevent It.

Authors:  Heather Armstrong; Michael Bording-Jorgensen; Stephanie Dijk; Eytan Wine
Journal:  Cancers (Basel)       Date:  2018-03-20       Impact factor: 6.639

5.  Synaptopodin-2 plays an important role in the metastasis of breast cancer via PI3K/Akt/mTOR pathway.

Authors:  Erjie Xia; Xiaofen Zhou; Adheesh Bhandari; Xiaohua Zhang; Ouchen Wang
Journal:  Cancer Manag Res       Date:  2018-06-18       Impact factor: 3.989

6.  Clinical presentation and proteomic signature of patients with TANGO2 mutations.

Authors:  Nadja Mingirulli; Angela Pyle; Denisa Hathazi; Charlotte L Alston; Nicolai Kohlschmidt; Gina O'Grady; Leigh Waddell; Frances Evesson; Sandra B T Cooper; Christian Turner; Jennifer Duff; Ana Topf; Delia Yubero; Cristina Jou; Andrés Nascimento; Carlos Ortez; Angels García-Cazorla; Claudia Gross; Maria O'Callaghan; Saikat Santra; Maryanne A Preece; Michael Champion; Sergei Korenev; Efsthatia Chronopoulou; Majumdar Anirban; Germaine Pierre; Daniel McArthur; Kyle Thompson; Placido Navas; Antonia Ribes; Frederic Tort; Agatha Schlüter; Aurora Pujol; Raquel Montero; Georgia Sarquella; Hanns Lochmüller; Cecilia Jiménez-Mallebrera; Robert W Taylor; Rafael Artuch; Janbernd Kirschner; Sarah C Grünert; Andreas Roos; Rita Horvath
Journal:  J Inherit Metab Dis       Date:  2019-08-13       Impact factor: 4.982

7.  Recessive Mutations in SYNPO2 as a Candidate of Monogenic Nephrotic Syndrome.

Authors:  Youying Mao; Ronen Schneider; Peter F M van der Ven; Marvin Assent; Keerthika Lohanadan; Verena Klämbt; Florian Buerger; Thomas M Kitzler; Konstantin Deutsch; Makiko Nakayama; Amar J Majmundar; Nina Mann; Tobias Hermle; Ana C Onuchic-Whitford; Wei Zhou; Nandini Nagarajan Margam; Roy Duncan; Jonathan Marquez; Mustafa Khokha; Hanan M Fathy; Jameela A Kari; Sherif El Desoky; Loai A Eid; Hazem Subhi Awad; Muna Al-Saffar; Shrikant Mane; Richard P Lifton; Dieter O Fürst; Shirlee Shril; Friedhelm Hildebrandt
Journal:  Kidney Int Rep       Date:  2020-11-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.